Urinary Calculi
1
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Boston ScientificCA - Valencia
2 programs1
Navigator Ureteral Access SheathPhase 41 trial
Flexiva Pulse High Power Single-Use Laser FibersN/A1 trial
Active Trials
Autonomous TherapeuticsMD - Rockville
1 programFlexible ureteroscope with intelligent control of renal pelvic pressureN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Boston ScientificNavigator Ureteral Access Sheath
Boston ScientificFlexiva Pulse High Power Single-Use Laser Fibers
Autonomous TherapeuticsFlexible ureteroscope with intelligent control of renal pelvic pressure
Clinical Trials (3)
Total enrollment: 694 patients across 3 trials
Use of a Ureteral Access Sheath During Ureteroscopy and Its Effect on Stone Free Rate
Start: May 2005Est. completion: May 200944 patients
Phase 4Terminated
Flexiva Pulse Registry
Start: Nov 2021Est. completion: Oct 2023201 patients
N/ACompleted
NCT05201599Autonomous TherapeuticsFlexible ureteroscope with intelligent control of renal pelvic pressure
Treatment of Upper Urinary Tract Stones With a Diameter≤2cm by Intelligent Pressure-controlled Flexible Ureteroscope
Start: Aug 2021Est. completion: Jul 2022449 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.